Aster DM Healthcare Limited has informed the Exchange regarding Resignation of Dr Harsha Rajaram as CEO-Aster Digital Healthcare of the company w.e.f. September 30, 2025.

Kmp ResignedManagement Changes View source PDF Explain this filing

ASTERDM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.0%Reaction day

₹625.90

prior close

₹625.30

announcement price

In-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)+0.2%-0.1% vs market

Hospital peers, median of 20sector+0.1%-0.1% vs sector

On the reaction day the stock moved 0.1 pts less than Nifty Smallcap 250 and 0.1 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.2

10m

+0.4

15m

+0.5

30m

+0.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.0+0.2-0.1+0.1-0.1

Next day

+0.9+1.2-0.3+0.6+0.3

+2.7+2.1+0.6+0.1+2.6

+7.7+2.2+5.5+3.2+4.5

+5.3+2.3+3.0+2.3+2.9

+11.2+1.7+9.4+1.0+10.2

+10.1+2.7+7.4+2.0+8.1

15d

+14.9+3.5+11.5+6.9+8.1

+11.5+4.5+7.0+4.2+7.3

+6.9+0.6+6.3-1.5+8.4

-2.3-1.0-1.3-3.0+0.6

UpDownMarket · Nifty Smallcap 250Sector · Hospital peers, median of 20Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Aster DM Healthcare has informed the stock exchanges that Dr. Harsha Rajaram, CEO of Aster Digital Health and a Senior Management Personnel, has resigned from the company effective close of business hours on September 30, 2025. The resignation has been attributed to personal commitments. The company has attached the resignation letter (dated July 2, 2025) and a disclosure annexure as required under SEBI Listing Regulations. Dr. Harsha has offered to ensure a smooth transition during the handover period.

Likely market impact

This is a leadership change in a specific business vertical (digital health) rather than at the company or group CEO level, so direct stock impact is likely limited. Investors may watch for clarity on succession plans for the digital health vertical, which is a key growth area for the company.